Part 201 - LABELING
- Subpart A - GENERAL LABELING PROVISIONS (§§ 201.1 — 201.26)
- Subpart B - LABELING REQUIREMENTS FOR PRESCRIPTION DRUGS AND/OR INSULIN (§§ 201.50 — 201.58)
- Subpart C - LABELING REQUIREMENTS FOR OVER-THE-COUNTER DRUGS (§§ 201.60 — 201.80)
- Subpart D - EXEMPTIONS FROM ADEQUATE DIRECTIONS FOR USE (§§ 201.100 — 201.129)
- Subpart E - OTHER EXEMPTIONS (§§ 201.150 — 201.161)
- Subpart F - LABELING CLAIMS FOR DRUGS IN DRUG EFFICACY STUDY (§ 201.200)
- Subpart G - SPECIFIC LABELING REQUIREMENTS FOR SPECIFIC DRUG PRODUCTS (§§ 201.300 — 201.328)
- Appendix A to Part 201 - Examples of Graphic Enhancements Used by FDA